These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 32753691)

  • 1. Publisher Correction: Pyroglutamic acidosis as a cause for high anion gap metabolic acidosis: a prospective study.
    Raibman Spector S; Mayan H; Loebstein R; Markovits N; Priel E; Massalha E; Shafir Y; Gueta I
    Sci Rep; 2020 Aug; 10(1):13397. PubMed ID: 32753691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyroglutamic Acidemia: An Underrecognized and Underdiagnosed Cause of High Anion Gap Metabolic Acidosis - A Case Report and Review of Literature.
    Venkataraman SS; Regone R; Ammar HM; Govindu RR
    Cureus; 2019 Jul; 11(7):e5229. PubMed ID: 31565630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyroglutamic acidemia: a cause of high anion gap metabolic acidosis.
    Dempsey GA; Lyall HJ; Corke CF; Scheinkestel CD
    Crit Care Med; 2000 Jun; 28(6):1803-7. PubMed ID: 10890623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profound metabolic acidosis from pyroglutamic acidemia: an underappreciated cause of high anion gap metabolic acidosis.
    Green TJ; Bijlsma JJ; Sweet DD
    CJEM; 2010 Sep; 12(5):449-52. PubMed ID: 20925168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyroglutamic acidosis as a cause for high anion gap metabolic acidosis: a prospective study.
    Raibman Spector S; Mayan H; Loebstein R; Markovits N; Priel E; Massalha E; Shafir Y; Gueta I
    Sci Rep; 2019 Mar; 9(1):3554. PubMed ID: 30837497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent high anion gap metabolic acidosis secondary to 5-oxoproline (pyroglutamic acid).
    Tailor P; Raman T; Garganta CL; Njalsson R; Carlsson K; Ristoff E; Carey HB
    Am J Kidney Dis; 2005 Jul; 46(1):e4-10. PubMed ID: 15983950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent Pyroglutamic Acidosis Related to Therapeutic Acetaminophen.
    Alhourani HM; Kumar A; George LK; Sarwar T; Wall BM
    Am J Med Sci; 2018 Apr; 355(4):387-389. PubMed ID: 29661353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An unusual cause of high anion gap metabolic acidosis: pyroglutamic acidemia. A case report.
    Romero JE; Htyte N
    Am J Ther; 2013; 20(5):581-4. PubMed ID: 21519223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyroglutamic acidosis in the setting of
    See AYS; Lau AZ; Thiruvengadam S
    Clin Case Rep; 2024 Aug; 12(8):e9243. PubMed ID: 39114848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of anion gap in the evaluation of a patient with metabolic acidosis.
    Vichot AA; Rastegar A
    Am J Kidney Dis; 2014 Oct; 64(4):653-7. PubMed ID: 25132207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [High anion gap metabolic acidosis (pyroglutamic acidosis) induced by chronic acetaminophen use].
    Tchougang Nono J; Mistretta V; Noirot I; Canivet JL; Damas P
    Rev Med Liege; 2018 Jan; 73(1):39-42. PubMed ID: 29388410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic acidosis and 5-oxoprolinuria induced by flucloxacillin and acetaminophen: a case report.
    Lanoy C; Bouckaert Y
    J Med Case Rep; 2016 Jun; 10(1):184. PubMed ID: 27339215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased anion gap metabolic acidosis as a result of 5-oxoproline (pyroglutamic acid): a role for acetaminophen.
    Fenves AZ; Kirkpatrick HM; Patel VV; Sweetman L; Emmett M
    Clin J Am Soc Nephrol; 2006 May; 1(3):441-7. PubMed ID: 17699243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Publisher Correction: Bridging the gap between measurements and modelling: a cardiovascular functional avatar.
    Casas B; Lantz J; Viola F; Cedersund G; Bolger AF; Carlhäll CJ; Karlsson M; Ebbers T
    Sci Rep; 2020 Jan; 10(1):1717. PubMed ID: 31996774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetaminophen-induced anion gap metabolic acidosis secondary to 5-oxoproline: a case report.
    Abkur TM; Mohammed W; Ali M; Casserly L
    J Med Case Rep; 2014 Dec; 8():409. PubMed ID: 25479831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High anion gap metabolic acidosis secondary to pyroglutamic aciduria (5-oxoprolinuria): association with prescription drugs and malnutrition.
    Brooker G; Jeffery J; Nataraj T; Sair M; Ayling R
    Ann Clin Biochem; 2007 Jul; 44(Pt 4):406-9. PubMed ID: 17594793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetaminophen-induced anion gap metabolic acidosis and 5-oxoprolinuria (pyroglutamic aciduria) acquired in hospital.
    Humphreys BD; Forman JP; Zandi-Nejad K; Bazari H; Seifter J; Magee CC
    Am J Kidney Dis; 2005 Jul; 46(1):143-6. PubMed ID: 15983968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired pyroglutamic acidaemia in a critically ill patient with chronic paracetamol use: A case report.
    Connolly L; Briggs E
    SAGE Open Med Case Rep; 2022; 10():2050313X211068561. PubMed ID: 35035973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Publisher Correction: Intermittent metabolic switching, neuroplasticity and brain health.
    Mattson MP; Moehl K; Ghena N; Schmaedick M; Cheng A
    Nat Rev Neurosci; 2020 Aug; 21(8):445. PubMed ID: 32606453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Publisher Correction: MEMOTE for standardized genome-scale metabolic model testing.
    Lieven C; Beber ME; Olivier BG; Bergmann FT; Ataman M; Babaei P; Bartell JA; Blank LM; Chauhan S; Correia K; Diener C; Dräger A; Ebert BE; Edirisinghe JN; Faria JP; Feist AM; Fengos G; Fleming RMT; García-Jiménez B; Hatzimanikatis V; van Helvoirt W; Henry CS; Hermjakob H; Herrgård MJ; Kaafarani A; Kim HU; King Z; Klamt S; Klipp E; Koehorst JJ; König M; Lakshmanan M; Lee DY; Lee SY; Lee S; Lewis NE; Liu F; Ma H; Machado D; Mahadevan R; Maia P; Mardinoglu A; Medlock GL; Monk JM; Nielsen J; Nielsen LK; Nogales J; Nookaew I; Palsson BO; Papin JA; Patil KR; Poolman M; Price ND; Resendis-Antonio O; Richelle A; Rocha I; Sánchez BJ; Schaap PJ; Sheriff RSM; Shoaie S; Sonnenschein N; Teusink B; Vilaça P; Vik JO; Wodke JAH; Xavier JC; Yuan Q; Zakhartsev M; Zhang C
    Nat Biotechnol; 2020 Apr; 38(4):504. PubMed ID: 32265554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.